Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study

OBJECTIVE: To assess the risk of select safety outcomes including endometrial cancer, endometrial hyperplasia, and breast cancer among women using conjugated estrogens/bazedoxifene (CE/BZA) as compared with estrogen/progestin combination hormone therapy (EP). METHODS: We conducted a new-user cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Sarah R., Governor, Samuel, Daniels, Kimberly, Seals, Ryan M., Ziyadeh, Najat J., Wang, Florence T., Dai, Dingwei, Mcmahill-Walraven, Cheryl N., Shuminski, Patty, Frajzyngier, Vera, Zhou, Xiaofeng, Shen, Rongjun, Garg, Renu K., Fournakis, Nicole, Lanes, Stephan, Beachler, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389232/
https://www.ncbi.nlm.nih.gov/pubmed/37449720
http://dx.doi.org/10.1097/GME.0000000000002217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389232/
https://www.ncbi.nlm.nih.gov/pubmed/37449720
http://dx.doi.org/10.1097/GME.0000000000002217

Ejemplares similares